Goldman Sachs has moved from an unaccustomed fifth place in the global mergers and acquisitions rankings to second after being appointed as the sole adviser to US healthcare products company Johnson & Johnson on a $20bn-plus takeover.
Johnson & Johnson said in a statement that it had agreed to acquire Synthes, an orthopaedic devices manufacturer for Sfr159 per share, or $21.3bn.